Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.003
Neutral
RSI(14)
48.253
Neutral
STOCH(KDJ)(9,3,3)
28.894
Sell
ATR(14)
0.073
Low Volatility
CCI(14)
-5.890
Neutral
Williams %R
43.529
Buy
TRIX(12,20)
-0.005
Sell
StochRSI(14)
0.000
Oversold
Search
TherapeuticsMD Inc
TXMDAdd to Watchlist
2.030USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
23.50MMarket Cap
130.46P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-1.46%
1 Month
-8.14%
6 Months
-6.02%
Year to Date
+24.54%
1 Year
+81.25%
Key Figures
2.030Open
2.056High
9.54KVolume
130.46P/E TTM
--P/E Dynamic
--Dividend TTM
0.08%Turnover Ratio
2.030Prev. Close
2.020Low
13.79KTurnover
LossP/E Static
0.87P/B
0.00%Div Yield TTM
0.23%ROA
2.95052wk High
0.51Volume Ratio
-2.18MNet Profit
11.57MShares
0.0156EPS TTM
0.60Beta
0.32%ROE
0.98152wk Low
1.79%Amplitude
100.00%Gross Margin
23.50MMarket Cap
-0.78Reward/Risk
4.87%Risk Rate
TradingKey Stock Score of TherapeuticsMD Inc
Currency: USD Updated: 2026-07-31Key Insights
TherapeuticsMD Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 122 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
TherapeuticsMD Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
TherapeuticsMD Inc Highlights
StrengthsRisks
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 132.10% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.02M.
Overvalued
The company’s latest PE is 130.46, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.82M shares, increasing 9.99% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
TherapeuticsMD Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
2.050
Sell
MA10
2.054
Sell
MA20
2.022
Buy
MA50
2.053
Sell
MA100
2.081
Sell
MA200
1.965
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
TherapeuticsMD Inc Info
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Ticker SymbolTXMD
CompanyTherapeuticsMD Inc
CEOWalker (Marlan D)
Websitehttps://www.therapeuticsmd.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of TherapeuticsMD Inc (TXMD)?
The current price of TherapeuticsMD Inc (TXMD) is 2.04.
What is the symbol of TherapeuticsMD Inc?
The ticker symbol of TherapeuticsMD Inc is TXMD.
What is the 52-week high of TherapeuticsMD Inc?
The 52-week high of TherapeuticsMD Inc is 2.95.
What is the 52-week low of TherapeuticsMD Inc?
The 52-week low of TherapeuticsMD Inc is 0.98.
What is the market capitalization of TherapeuticsMD Inc?
The market capitalization of TherapeuticsMD Inc is 23.55M.
What is the Earnings Per Share (EPS TTM) of TherapeuticsMD Inc (TXMD)?
The Earnings Per Share (EPS TTM) of TherapeuticsMD Inc (TXMD) is -0.05.